Research Use Only • Third-Party COA Verified • ≥99% Purity • Fast U.S. Shipping
CJC-1295/Ipamorelin (No DAC) 10mg
$70.00
Synergistic GH-support blend combining extended GHRH receptor activation with targeted ghrelin receptor stimulation for enhanced effects. FOR RESEARCH USE ONLY.
This combination preparation pairs CJC-1295 (No DAC) with Ipamorelin in a single 10mg lyophilized vial, providing researchers with a convenient dual-peptide formulation for studying synergistic growth hormone releasing mechanisms.
CJC-1295 (No DAC) is a GHRH analog that stimulates GH release through the GHRH receptor, while Ipamorelin is a selective growth hormone secretagogue that acts through the ghrelin receptor. Research suggests that co-administration of these peptides may produce amplified GH release compared to either peptide alone, without significantly elevating cortisol or prolactin levels.
Each vial contains a total of 10mg of the CJC-1295/Ipamorelin blend, produced under strict manufacturing standards with purity exceeding 99% as confirmed by HPLC and mass spectrometry. This combination format reduces preparation time and ensures consistent dosing ratios across experiments.
The CJC-1295/Ipamorelin combination models dual-pathway GH stimulation: GHRH-receptor activation raises pulse amplitude while ghrelin-receptor agonism increases pulse frequency and suppresses somatostatin. Blended formulations give researchers a fixed-ratio tool for studying this synergy, which single-compound protocols must otherwise titrate independently.
*For best results, this product should be reconstituted with Hospira Bacteriostatic Water. Use of any alternative diluent is at your own discretion, and we are not responsible for any resulting changes in appearance or consistency, including cloudiness or gelling of the research product.*
Store lyophilized at -20C. Reconstituted at 2-8C, use within 60 days.
For research and laboratory use only.



Reviews
There are no reviews yet.